In addition, Nielsen et al. reported that a lower CYT-1/CYT-2 ratio was accompanied by decreased tumor growth in ER+ breast cancer cell lines, and that a lower CYT-1/CYT-2 ratio led to the reduction of phosphorylated Akt [24]. The gene discussed is AKT1; the disease is neoplasm.